Search Results - "Bazarbachi, Abdul Hamid"

Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities by Al Hamed, Rama, Bazarbachi, Abdul Hamid, Mohty, Mohamad

“…Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the population worldwide. The virus can establish a lifelong latent…”
Get full text

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma by Samur, Mehmet Kemal, Fulciniti, Mariateresa, Aktas Samur, Anil, Bazarbachi, Abdul Hamid, Tai, Yu-Tzu, Prabhala, Rao, Alonso, Alejandro, Sperling, Adam S., Campbell, Timothy, Petrocca, Fabio, Hege, Kristen, Kaiser, Shari, Loiseau, Hervé Avet, Anderson, Kenneth C., Munshi, Nikhil C.

“…BCMA targeting chimeric antigen receptor (CAR) T cell therapy has shown deep and durable responses in multiple myeloma. However, relapse following therapy is…”
Get full text

Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party by Bazarbachi, Abdul-Hamid, Labopin, Myriam, Raiola, Anna Maria, Blaise, Didier, Arcese, William, Santarone, Stella, Koc, Yener, Bramanti, Stefania, Kulagin, Alexander, Kwon, Mi, Sica, Simona, Sanz, Jaime, Brissot, Eolia, Nagler, Arnon, Ciceri, Fabio, Mohty, Mohamad

“…The optimal choice for graft-versus-host disease (GVHD) prophylaxis in haploidentical stem cell transplantation (haplo-SCT) remains debatable. Posttransplant…”
Get full text

Current status of autologous stem cell transplantation for multiple myeloma by Al Hamed, Rama, Bazarbachi, Abdul Hamid, Malard, Florent, Harousseau, Jean-Luc, Mohty, Mohamad

“…More than 30 years after its introduction, autologous stem cell transplantation (ASCT) remains the standard of care for young patients with newly diagnosed…”
Get full text

Timing and outcomes of second‐line therapy in the era of daratumumab‐based frontline therapy in AL amyloidosis by Bazarbachi, Abdul‐Hamid, Bhutani, Divaya, Radhakrishnan, Jai, Mapara, Markus, Maurer, Mathew S., Lentzsch, Suzanne, Chakraborty, Rajshekhar

Get full text

Comprehensive Review of AL amyloidosis: some practical recommendations by Al Hamed, Rama, Bazarbachi, Abdul Hamid, Bazarbachi, Ali, Malard, Florent, Harousseau, Jean-Luc, Mohty, Mohamad

“…Amyloid light chain (AL) amyloidosis is among the more common and more severe of the amyloidoses usually involving the slow proliferation of a…”
Get full text

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia by Bou-Fakhredin, Rayan, Bazarbachi, Abdul-Hamid, Chaya, Bachar, Sleiman, Joseph, Cappellini, Maria Domenica, Taher, Ali T

“…Iron overload (IOL) due to increased intestinal iron absorption constitutes a major clinical problem in patients with non-transfusion-dependent thalassemia…”
Get full text

Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update by Bazarbachi, Abdul Hamid, Al Hamed, Rama, Malard, Florent, Bazarbachi, Ali, Harousseau, Jean-Luc, Mohty, Mohamad

“…The current standard of care model for newly diagnosed fit multiple myeloma (NDMM) patients is the sequential treatment of induction, high dose melphalan,…”
Get full text

Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies by Mohty, Razan, Dulery, Rémy, Bazarbachi, Abdul Hamid, Savani, Malvi, Hamed, Rama Al, Bazarbachi, Ali, Mohty, Mohamad

“…Hodgkin lymphoma is a highly curable disease. Although most patients achieve complete response following frontline therapy, key unmet clinical needs remain…”
Get full text

Relapsed refractory multiple myeloma: a comprehensive overview by Bazarbachi, Abdul Hamid, Al Hamed, Rama, Malard, Florent, Harousseau, Jean-Luc, Mohty, Mohamad

“…Most patients with relapsed/refractory multiple myeloma (RRMM) have been treated with drug combinations including a proteasome inhibitor (PI) and/or an…”
Get full text

MM-295 Timing And Outcomes of Second-Line Therapy in the Era of Daratumumab-Based Frontline Therapy in Amyloidosis by Hamid Bazarbachi, Abdul-Hamid, Bhutani, Divaya, Radhakrishnan, Jai, Mapara, Markus, Maurer, Mathew, Lentzsch, Suzanne, Chakraborty, Rajshekhar

“…The ANDROMEDA trial established daratumumab with bortezomib-cyclophosphamide-dexamethasone (Dara-VCd) as the standard of care for newly diagnosed…”
Get full text

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real‐life perspective by Savani, Malvi, Dulery, Rémy, Bazarbachi, Abdul Hamid, Mohty, Razan, Brissot, Eolia, Malard, Florent, Bazarbachi, Ali, Nagler, Arnon, Mohty, Mohamad

“…Summary Myelofibrosis (MF) is a clonal stem cell neoplasm with heterogeneous clinical phenotypes and well‐established molecular drivers. Allogeneic…”
Get full text

Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party by Bazarbachi, Abdul Hamid, Al Hamed, Rama, Labopin, Myriam, Afanasyev, Boris, Hamladji, Rose-Marie, Beelen, Dietrich, Eder, Matthias, Scheid, Christof, Wu, Depei, Bunjes, Donald, Stepensky, Polina, Tischer, Johanna, Kröger, Nicolaus, Peric, Zina, Aljurf, Mahmoud, Giebel, Sebastian, Nagler, Arnon, Mohty, Mohamad

“…Treatment of relapsed/refractory acute lymphoblastic leukemia (RR-ALL) remains a clinical challenge with generally dismal prognosis. Allogeneic stem-cell…”
Get full text

High seroconversion rates amongst black and Hispanics with hematologic malignancies after SARS-CoV-2 vaccination by Shapiro, Lauren C., Thakkar, Astha, Gali, Radhika, Gonzalez-Lugo, Jesus D., Bazarbachi, Abdul-Hamid, Rahman, Shafia, Pradhan, Kith, Fehn, Karen, Abreu, Michelly, Kornblum, Noah, Gritsman, Kira, Goldfinger, Mendel, Shastri, Aditi, Mantzaris, Ioannis, Braunschweig, Ira, Halmos, Balazs, Verma, Amit, McCort, Margaret, Bachier-Rodriguez, Lizamarie, Sica, R. Alejandro

Get full text

Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party by Bazarbachi, Abdul Hamid, Al Hamed, Rama, Labopin, Myriam, Halaburda, Kazimierz, Labussiere, Helene, Bernasconi, Paolo, Schroyens, Wilfried, Gandemer, Virginie, Schaap, Nicolaas P. M., Loschi, Michael, Jindra, Pavel, Snowden, John, Wu, Depei, Guffroy, Blandine, Rovira, Montserrat, Chantepie, Sylvain P., Poiré, Xavier, Lopez-Corral, Lucia, Nikolousis, Manos, Pelosini, Matteo, Ciceri, Fabio, Baron, Frederic, Bazarbachi, Ali, Corbacioglu, Selim, Savani, Bipin N., Peric, Zinaida, Nagler, Arnon, Carreras, Enric, Mohty, Mohamad

“…Allogeneic hematopoietic cell transplantation (alloHCT) is a complex, potentially fatal therapy featuring a myriad of complications. Triggering event(s) of…”
Get full text

ABCL-161 Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine by Narvel, Hiba, Yakkali, Shreyas, Bazarbachi, Abdul-hamid, Wang, Shuai, de Castro, Alyssa, Narvel, Adnan, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Gritsman, Kira, Goldfinger, Mendel, Kornblum, Noah, Shastri, Aditi, Mcneill, Katharine, Janakiram, Murali, Mantzaris, Ioannis, Verma, Amit, Braunschweig, Ira, Sica, R. Alejandro

Get full text

TCL-150 Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma by Narvel, Hiba, Bazarbachi, Abdul-Hamid, Reef, Daniel, Patel, Riya, Thakkar, Astha, Zareef, Sumaira, de Castro, Alyssa, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Gritsman, Kira, Goldfinger, Mendel, Wang, Yanhua, Kornblum, Noah, Shastri, Aditi, Mantzaris, Ioannis, Shah, Nishi, Braunschweig, Ira, Verma, Amit, Ye, Hilda, Sica, R Alejandro

“…Adult T-cell leukemia/lymphoma (ATLL) is a rare, human T-cell lymphotropic virus 1 (HTLV-1)-driven malignancy with treatment challenges and a dismal prognosis…”
Get full text

ABCL-038 HIV Status Affects Access to Autologous Stem Cell Transplant in Primary Central Nervous System B-Cell Lymphomas in a Minority Rich, Ethnically Diverse and Socioeconomically Disadvantaged Population at Montefiore Medical Center/Albert Einstein College of Medicine by Narvel, Hiba, Vegivinti, Charan, Reef, Daniel, Vikash, Sindhu, Wang, Shuai, Bazarbachi, Abdul-Hamid, Narvel, Adnan, de Castro, Alyssa, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Nugent, Latoya Townsend, Gritsman, Kira, Goldfinger, Mendel, Kornblum, Noah, Shastri, Aditi, Mantzaris, Ioannis, Verma, Amit, Braunschweig, Ira, Sica, Alejandro

Get full text

Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant by Bazarbachi, Abdul Hamid, Al Hamed, Rama, Malard, Florent, Mohty, Mohamad, Bazarbachi, Ali

“…FMS-like tyrosine kinase 3 (FLT3) mutations are one of the most frequently encountered genetic alterations in acute myeloid leukemia (AML), and are generally…”
Get full text

Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma by Bazarbachi, Abdul-Hamid, Reef, Daniel, Narvel, Hiba, Patel, Riya, Al Hamed, Rama, Vikash, Sindhu, Neupane, Karun, Atalla, Eleftheria, Thakkar, Astha, Rahman, Shafia, Shah, Urvi, Adrianzen-Herrera, Diego, Quinn, Ryann, Zareef, Sumaira, Rabinovich, Emma, De Castro, Alyssa, Joseph, Felisha, Gillick, Kailyn, Mustafa, Jennat, Khatun, Fariha, Lombardo, Amanda, Townsend-Nugent, Latoya, Abreu, Michelly, Chambers, Nicole, Elkind, Richard, Shi, Yang, Wang, Yanhua, Derman, Olga, Gritsman, Kira, Steidl, Ulrich, Goldfinger, Mendel, Kornblum, Noah, Shastri, Aditi, Mantzaris, Ioannis, Bachier-Rodriguez, Liza, Shah, Nishi, Cooper, Dennis, Verma, Amit, Ye, Bihui Hilda, Janakiram, Murali, Sica, Roberto Alejandro

“…Adult T-cell leukemia/lymphoma (ATLL) remains challenging to treat and has dismal outcome. Allogeneic stem-cell transplantation (allo-SCT) has promising…”
Get full text